Balyasny Asset Management LLC Immunome Inc. Put Options Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMNM
# of Institutions
125Shares Held
45.7MCall Options Held
74KPut Options Held
2.04M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.5MShares$57.2 Million0.04% of portfolio
-
Redmile Group, LLC San Francisco, CA4.83MShares$50.2 Million3.87% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$40.3 Million1.86% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$39.1 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.46MShares$35.9 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $126M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...